Worth Watching Stocks : AbbVie Inc. (NYSE:ABBV), Alcatel Lucent SA (ADR) (NYSE:ALU), SCANA Corp. (NYSE:SCG), Amicus Therapeutics, Inc. (NASDAQ:FOLD), AutoZone, Inc. (NYSE:AZO)

AbbVie Inc. (NASDAQ:ABBV) declared a quarterly dividend on Friday, September 19th. Stockholders of record on Wednesday, October 15th will be given a dividend of 0.42 per share on Monday, November 17th. This represents a $1.68 dividend on an annualized basis and a yield of 2.88%. The ex-dividend date of this dividend is Friday, October 10th. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 21.70% and weekly performance is 0.09%. On last trading day company shares ended up $56.72. AbbVie Inc. (NYSE:ABBV) distance from 50-day simple moving average (SMA50) is 1.32%.

Alcatel-Lucent (NYSE:ALU) has today opened an innovative facility in Tokyo designed to give service providers and enterprise customers hands-on experience in the co-creation of new ultra-broadband and cloud-based services and applications. The Alcatel-Lucent Customer Network Center (CNC) is a first-of-its-kind in Japan – one of the world’s most advanced telecommunications markets – and has been created to make networking trends, most notably the trend towards cloud-based networking, tangible for customers. In the CNC, Alcatel-Lucent customers can participate in interactive demonstrations and co-creation opportunities that lead to the creation of new business models. Alcatel Lucent SA (ADR) (NYSE:ALU) shares moved down -9.51% in last trading session and ended the day at $2.57. ALU Gross Margin is 33.00% and its return on assets is -2.10%. Alcatel Lucent SA (ADR) (NYSE:ALU) quarterly performance is -25.72%.

SCANA Corporation (NYSE: SCG) will release its third quarter earnings on Thursday, October 30, 2014, before the market opens. On 09 October, SCANA Corp. (NYSE:SCG) shares moved down -1.76% and was closed at $48.48. SCG EPS growth in last 5 year was 2.70%. SCANA Corp. (NYSE:SCG) year to date (YTD) performance is 6.55%.

Amicus Therapeutics (NASDAQ:FOLD) CFO William D. Baird III sold 10,000 shares of the stock on the open market in a transaction dated Friday, October 3rd. The shares were sold at an average price of $7.00, for a total value of $70,000.00. Following the completion of the transaction, the chief financial officer now directly owns 100,000 shares in the company, valued at approximately $700,000. Amicus Therapeutics, Inc. (NASDAQ:FOLD) ended the last trading day at $6.36. Company weekly volatility is calculated as 7.77% and price to cash ratio as 6.42. Amicus Therapeutics, Inc. (NASDAQ:FOLD) showed a weekly performance of -3.05%.

AutoZone Inc. (NYSE:AZO) has been given a “BBB” credit rating by Morningstar. The investment research firm’s “BBB” rating suggests that the company is a moderate default risk. They also gave their stock a three star rating. AutoZone, Inc. (NYSE:AZO) shares moved down -1.83% in last trading session and ended the day at $508.32. AZO Gross Margin is 52.10% and its return on assets is 20.70%. AutoZone, Inc. (NYSE:AZO) quarterly performance is -4.71%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone